|Articles|June 1, 2011
- Pharmaceutical Executive-06-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - June 2011
Emerging Pharma Leaders 2011
Advertisement
Articles in this issue
almost 15 years ago
Educating Physiciansalmost 15 years ago
To Genzyme, Quality Data Depends on Quality Governancealmost 15 years ago
Drugstore Vaccinationsalmost 15 years ago
A Lack of Informationalmost 15 years ago
Getting IT Togetheralmost 15 years ago
The Futuristic Insightalmost 15 years ago
Optimizing your Value with Payersalmost 15 years ago
Managing Product Lifecyclealmost 15 years ago
To Screen or Not to Screen?almost 15 years ago
Start Serious, Become BolderNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5